What are Mission Vision & Core Values of IBA Company?

The mission statement, "Protect, Enhance and Save Lives," immediately establishes IBA's core purpose. It's a clear and concise articulation of the company's commitment, driving all its activities and decisions.

IBA's primary customers are hospitals and industrial facilities globally. These entities rely on IBA's technology for critical applications, highlighting the global scope of their impact. The company's global presence is essential for achieving its mission.

IBA offers proton therapy systems, dosimetry solutions, and related services. These offerings directly contribute to the mission by providing advanced cancer treatment and ensuring the safety of medical devices. In 2023, the global proton therapy market was valued at USD 1.1 billion, with projections of significant growth in the coming years.

The unique value lies in IBA's advanced particle accelerator technology. This technology is pivotal in cancer treatment and sterilization, directly contributing to the mission's objectives. IBA's technology is at the forefront of innovation in these fields.

The mission is reflected in IBA's business operations, particularly through the development of proton therapy systems. These systems offer a highly advanced form of radiation therapy. In 2024, over 100,000 patients worldwide received proton therapy treatment, demonstrating the impact of IBA's technology.

The mission is strongly customer-centric, focusing on the impact of IBA's technology on human health and safety. This focus guides the company's strategic goals and objectives, ensuring that all efforts contribute to protecting, enhancing, and saving lives. For more insights into IBA's broader strategies, consider reading about the Marketing Strategy of IBA.

IBA Company's vision is deeply rooted in technological innovation. This includes continuous research and development to enhance existing technologies and create new ones. Their focus is on advancing particle accelerator technology, particularly in proton therapy delivery techniques, such as DynamicARC and ConformalFLASH, and exploring carbon-ion radiation therapy systems. This commitment to innovation is a core element of the IBA Company Vision.

IBA Company's aspirations extend to maintaining and expanding its leadership position in the global market. This involves not only technological advancements but also a strong market presence and strategic expansion. The IBA Company Goals include increasing their market share and solidifying their position as a key player in the industry. Their success in 2024, with increased revenue and a return to profitability, supports this vision.

A significant aspect of IBA Company's vision involves improving healthcare outcomes. This is achieved through the application of their particle accelerator technology in cancer treatment, specifically proton therapy. By making advanced radiation therapy more accessible and effective, IBA Company aims to significantly impact patient care globally. This aligns with the IBA Company Objectives of improving patient outcomes.

The IBA Company Vision also encompasses the use of their technology in various industrial applications. This includes sterilization, industrial imaging, and other areas where particle accelerators can provide innovative solutions. This diversification ensures that IBA Company's impact extends beyond healthcare, contributing to advancements in multiple sectors. The IBA Company Philosophy is centered on innovation and impact.

IBA Company's future plans include strategic expansion and growth. This is supported by a strong backlog and pipeline entering 2025, indicating their commitment to increasing their global footprint and market presence. This expansion strategy is crucial for achieving the IBA Company's long-term vision. Read more about the Target Market of IBA to understand their global strategy.

Underpinning the IBA Company Vision is a commitment to excellence in all aspects of its operations. This involves maintaining high standards in research, development, manufacturing, and customer service. This dedication ensures the company remains competitive and delivers on its promises. This is reflected in the IBA Company's guiding principles.

IBA's vision for the future is a driving force behind its product development strategies. The company consistently invests in research and development to create innovative solutions that address unmet needs in healthcare.

IBA's strategic goals include expanding its global footprint to make its life-saving technologies accessible to a wider audience. This is evident in its efforts to secure a significant market share in proton therapy worldwide.

The financial performance of IBA is a direct reflection of its success in implementing its mission-driven strategy. The company's financial results underscore the effectiveness of its strategic decisions.

IBA's core values, which are intrinsically linked to its mission and vision, guide day-to-day operations. This emphasis on quality, safety, and ethical conduct ensures that all activities align with the company's core purpose.

Long-term planning at IBA is guided by its aspirations for continued innovation and market leadership. These plans drive investments in R&D and global expansion, ensuring sustainable value creation.

IBA's financial achievements in 2024, including record-high revenue of €498.2 million (a 7% increase from 2023) and a return to profitability with a net result of €9.3 million, demonstrate its commitment to its values. The all-time high backlog of €1.5 billion at the end of 2024 further validates the company's strategic direction.

Leadership plays a critical role in reinforcing the company's mission, vision, and core values. CEO Olivier Legrain's statements consistently highlight the company's focus on backlog conversion, profitability, and future growth, all underpinned by its core purpose, reflecting the .

The mission and vision are communicated to stakeholders through various channels, including press releases, investor presentations, and the company website, ensuring transparency and reinforcing the company's direction. Consistent reporting of financial results and strategic initiatives reinforces the company's commitment to its .

Concrete examples of alignment between stated values and actual business practices are evident in IBA's investments and certifications. The investment in PanTera to address the supply shortage of a key component for radiopharmaceuticals demonstrates a commitment to addressing critical needs in healthcare, reflecting the .

While specific formal programs for ensuring alignment were not detailed, the company's reporting structure and emphasis on performance and profitability suggest a system of accountability linked to strategic objectives. IBA's improved B Corp score provides external validation of its commitment to social and environmental performance, aligning with a value of responsibility.